Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: October 7, 2022

Pentostatin - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic drug sources for pentostatin and what is the scope of freedom to operate?

Pentostatin is the generic ingredient in two branded drugs marketed by Hospira Inc, Rising, and West-ward Pharms Int, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentostatin. One supplier is listed for this compound.

Drug Prices for pentostatin

See drug prices for pentostatin

Recent Clinical Trials for pentostatin

Identify potential brand extensions & 505(b)(2) entrants

Scripps HealthPhase 2
California Institute for Regenerative Medicine (CIRM)Phase 1
City of Hope Medical CenterPhase 1

See all pentostatin clinical trials

Pharmacology for pentostatin
Medical Subject Heading (MeSH) Categories for pentostatin

US Patents and Regulatory Information for pentostatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int PENTOSTATIN pentostatin INJECTABLE;INJECTION 077841-001 Aug 7, 2007 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rising PENTOSTATIN pentostatin INJECTABLE;INJECTION 203554-001 Sep 19, 2014 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.